Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology.
Saved in:
| Title: | Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology. |
|---|---|
| Authors: | Sinclair JMA; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Kalk NJ; Department of Addictions, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; South London and Maudsley NHS Foundation Trust, London, UK., Kaar SJ; Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester, Manchester, UK.; Greater Manchester Mental Health NHS Foundation Trust, Addictions Services, Chapman-Barker Unit Manchester, UK., Agabio R; Department of Biomedical Sciences, Section of Neurosciences and Clinical Pharmacology, University of Cagliari, Cagliari, Italy., Arunogiri S; Turning Point, Eastern Health, Melbourne, VIC, Australia.; Monash University, Melbourne, VIC, Australia., Bisaga A; Columbia University College of Physicians and Surgeons, New York, NY, USA., Chesney E; Department of Addictions, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; South London and Maudsley NHS Foundation Trust, London, UK., Daly C; Greater Manchester Mental Health NHS Foundation Trust, Addictions Services, Chapman-Barker Unit Manchester, UK., Dewhurst J; Addiction and Homeless Services, Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK., Freeman TP; Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath, UK., Ghosh A; Postgraduate Institute of Medical Education & Research, Chandigarh, India., Hemrage S; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Leggio L; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA.; Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, MD, USA., Lingford-Hughes A; Imperial College London, London, UK.; Central North West London NHS Foundation Trust, London, UK., Matheson C; University of Stirling, Stirling, Scotland., McKetin R; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia., Paterson LM; Imperial College London, London, UK., Roberts E; Department of Addictions, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; South London and Maudsley NHS Foundation Trust, London, UK., Robson D; Department of Addictions, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Scott J; Bristol Medical School, University of Bristol, Bristol, UK.; Connect (Turning Point Drug & Alcohol Service), Wiltshire, UK., Welch S; Addiction Psychiatrist (retired), Gloustershire, UK. |
| Source: | Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2026 Feb; Vol. 40 (2), pp. 227-272. Date of Electronic Publication: 2026 Feb 23. |
| Publication Type: | Journal Article; Practice Guideline; Review |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 8907828 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7285 (Electronic) Linking ISSN: 02698811 NLM ISO Abbreviation: J Psychopharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1461-7285 |
|---|---|
| DOI: | 10.1177/02698811251399593 |
